Journal History

2013 The inaugural issue is released, and Vaccines published as a quarterly journal.
2015 Indexed by Scopus (Elsevier), PubMed (NLM) and Emerging Sources Citation Index (ESCI, Web of Science). Full-text papers are archived in the US National Library of Medicine's (NLM) PubMed Central (PMC).
2017 Vaccines launched its first edition of Travel Awards. The journal Twitter account was established.
2018 Indexed by the Science Citation Index Expanded (SCIE – Web of Science) and BIOSIS Previews (Web of Science).
2019 Vaccines received a first Impact Factor of 4.76. The journal ranks 39/158 (Q1) in the 'Immunology' category and 25/136 (Q1) in the "Medicine, Research & Experimental" category.
2020 Vaccines published its 1000th paper.
Vaccines established the following Sections:
Vaccine adjuvants 
Attenuated/Inactivated/Live and Vectored vaccines
Clinical Immunology
Cellular/molecular Immunology
Pathogens-host Immune Interface
Human Papillomavirus Vaccines
Hepatitis Virus Vaccines
2021 Vaccines established the following Sections:
COVID-19 Vaccines and Vaccination
PK/PD (Pharmacokinetic/Pharmacodynamic Modeling) Approaches for Vaccination Optimization
DNA and mRNA Vaccines


2013–2019 Editor-in-Chief: Prof. Dr. Diane M. Harper
2019–present Editor-in-Chief: Prof. Dr. Ralph A. Tripp

Section Editor-in-Chief

2019-present Section-Editor-in-Chief: Dr. Subbaya Subramanian for the section on Cancer Vaccines and Immunotherapy
Section-Editor-in-Chief: Dr. Romain Paillot for the section on Veterinary Vaccines
Section-Editor-in-Chief: Prof. Dr. Giuseppe La Torre for the section on Epidemiology
Section-Editor-in-Chief: Prof. Dr. Nirbhay Kumar for the section on Vaccines against (re)emerging and Tropical Infections Diseases
Section-Editor-in-Chief: Prof. Dr. Martin F. Bachmann for the section on Therapeutic Vaccines and Antibody Therapeutics
2020-present Section-Editor-in-Chief: Dr. Yee-Joo Tan for the section on Hepatitis Virus Vaccines
Section-Editor-in-Chief: Prof. Dr. François Meurens for the section on Pathogens-host Immune Interface
Section-Editor-in-Chief: Prof. Dr. Hans-Peter Hartung for the section on Cellular/Molecular Immunology
Section-Editor-in-Chief: Dr. Eduardo Gomez-Casado for the section on Vaccine Adjuvants
Section-Editor-in-Chief: Prof. Dr. Giampiero Girolomoni for the section on Clinical Immunology
Section-Editor-in-Chief: Prof. Dr. Nirbhay Kumar for the section on HIV Vaccines
2021-present Section-Editor-in-Chief: Prof. Dr. Luis Martinez-Sobrido for the section on COVID-19 Vaccines and Vaccination
Section-Editor-in-Chief: Prof. Dr. Hinh Ly for the section on Innate and Adaptive Immunity in Vaccination
Section-Editor-in-Chief: Prof. Dr. Jorge H. Leitão for the section on DNA and mRNA Vaccines
Section-Editor-in-Chief: Prof. Dr. Amine A. Kamen for the section on Attenuated/Inactivated/Live and Vectored Vaccines
Section-Editor-in-Chief: Dr. Ralph J. DiClemente for the section on Vaccines and Society
Back to TopTop